SCOLARI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 21.962
EU - Europa 17.415
AS - Asia 14.255
SA - Sud America 3.137
AF - Africa 494
OC - Oceania 86
Continente sconosciuto - Info sul continente non disponibili 26
Totale 57.375
Nazione #
US - Stati Uniti d'America 21.566
PL - Polonia 5.848
CN - Cina 4.724
SG - Singapore 4.401
UA - Ucraina 3.594
BR - Brasile 2.648
IT - Italia 2.528
HK - Hong Kong 2.050
DE - Germania 1.420
FI - Finlandia 1.141
VN - Vietnam 1.083
FR - Francia 772
TR - Turchia 583
GB - Regno Unito 551
IE - Irlanda 495
RU - Federazione Russa 478
IN - India 274
NG - Nigeria 241
BD - Bangladesh 229
JP - Giappone 212
AR - Argentina 204
CA - Canada 195
NL - Olanda 171
ID - Indonesia 161
MX - Messico 127
IQ - Iraq 109
SE - Svezia 93
AU - Australia 84
EC - Ecuador 76
ZA - Sudafrica 74
PK - Pakistan 54
CO - Colombia 53
ES - Italia 51
AT - Austria 47
MA - Marocco 47
SA - Arabia Saudita 45
PY - Paraguay 42
CZ - Repubblica Ceca 41
UZ - Uzbekistan 35
VE - Venezuela 35
MY - Malesia 32
BE - Belgio 29
EG - Egitto 29
CL - Cile 27
JO - Giordania 26
PE - Perù 26
EU - Europa 25
IR - Iran 23
KE - Kenya 22
TW - Taiwan 22
CH - Svizzera 21
TN - Tunisia 19
KZ - Kazakistan 18
AZ - Azerbaigian 17
KR - Corea 17
LT - Lituania 17
AE - Emirati Arabi Uniti 16
AL - Albania 16
NP - Nepal 16
UY - Uruguay 15
IL - Israele 14
DZ - Algeria 13
LV - Lettonia 13
ET - Etiopia 12
KG - Kirghizistan 12
PS - Palestinian Territory 12
RO - Romania 12
TH - Thailandia 12
PA - Panama 11
RS - Serbia 11
CR - Costa Rica 10
PT - Portogallo 10
BO - Bolivia 9
DO - Repubblica Dominicana 9
JM - Giamaica 9
PH - Filippine 9
TT - Trinidad e Tobago 9
BG - Bulgaria 8
MU - Mauritius 8
HN - Honduras 7
HU - Ungheria 7
LB - Libano 7
OM - Oman 7
AM - Armenia 6
GR - Grecia 6
SN - Senegal 6
BB - Barbados 5
GT - Guatemala 5
MK - Macedonia 5
SV - El Salvador 5
BW - Botswana 4
BY - Bielorussia 4
HR - Croazia 4
KH - Cambogia 4
KW - Kuwait 4
LK - Sri Lanka 4
LU - Lussemburgo 4
NO - Norvegia 4
UG - Uganda 4
BH - Bahrain 3
Totale 57.323
Città #
Warsaw 5.825
Jacksonville 2.276
Singapore 2.242
Hong Kong 2.016
Fairfield 2.014
Woodbridge 1.999
Ashburn 1.623
Houston 1.189
Princeton 970
The Dalles 951
Ann Arbor 928
Cambridge 872
Beijing 827
San Jose 814
Wilmington 770
Seattle 754
Nanjing 739
Helsinki 661
Dublin 488
Istanbul 460
Lauterbourg 431
Los Angeles 403
Chandler 401
New York 384
Ho Chi Minh City 322
Milan 315
Nanchang 296
Des Moines 240
Abuja 238
São Paulo 218
Dong Ket 216
Buffalo 214
Moscow 200
Council Bluffs 193
Changsha 185
Redondo Beach 185
Shenyang 178
Hebei 176
Brescia 168
Hanoi 158
Munich 131
Dearborn 127
San Diego 122
Memphis 121
Dallas 117
Tianjin 115
Shanghai 112
Jiaxing 110
Chicago 108
Santa Clara 105
Hangzhou 100
Rome 98
Rio de Janeiro 96
Phoenix 91
Jinan 90
San Francisco 88
Tokyo 88
Orem 84
Verona 79
Jakarta 74
Toronto 66
London 64
Nuremberg 64
Kocaeli 60
Kunming 57
Atlanta 53
Guangzhou 53
Brooklyn 52
Montreal 51
Belo Horizonte 47
Chennai 46
Lanzhou 41
Baghdad 40
Brasília 40
Curitiba 39
Ningbo 38
Frankfurt am Main 37
Paris 37
Zhengzhou 36
Bologna 35
Turku 35
Denver 34
Melbourne 34
Porto Alegre 34
Redwood City 34
Campinas 31
Dhaka 31
Amsterdam 30
Brno 30
Mumbai 30
Norwalk 30
Tashkent 30
Haiphong 29
Manchester 29
Augusta 28
Palermo 28
San Mateo 28
Da Nang 27
Stockholm 27
Amman 26
Totale 37.156
Nome #
The pathophysiology of IgA nephropathy 979
Trattamento del linfocele postoperatorio mediante instillazione su guida ecografica di polivinil-pirrolidone iodico. Casistica personale. 894
Genome-wide association study identifies susceptibility loci for IgA nephropathy 506
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 478
The copy number variation landscape of congenital anomalies of the kidney and urinary tract. 294
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway 289
Autoimmunity in membranous nephropathy targets aldose reductase and SOD2 289
Genetic drivers of kidney defects in the digeorge syndrome 288
Suprarenal aortic cross-clamping in the elective surgery of abdominal aortic aneurysms. Lessons from 68 cases out of consecutive survey of 746 abdominal aortic substitutions. 285
Insufficienza renale acuta e o subacuta richiedente dialisi in corso di malattia ateroembolica renale: impatto sulla sopravvivenza del paziente e del rene. 270
Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) 264
IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23 263
The importance of skin biopsy in the diverse clinical manifestations of cholesterol embolism. 262
Mutations in DSTYK and dominant urinary tract malformations. 260
A recessive gene for primary vesicoureteral reflux maps to chromosome 12p11-q13. 260
Clinical features and long-term outcome of nephrotic syndrome associated with heterozygous NPHS1 and NPHS2 mutations. 253
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. 252
PREDICTORS OF RENAL AND PATIENT OUTCOMES IN ATHEROEMBOLIC RENAL DISEASE: A PROSPECTIVE STUDY. 251
Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin 250
Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study 250
Defective intracellular trafficking of uromodulin mutant isoforms 249
Lack of association between dialysis modality and outcomes in atheroembolic renal disease 249
Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study 247
Infertility and hypergonadotropic hypogonadism as first evidence of hereditary apolipoprotein A-I amyloidosis 246
The Case | Cystic renal disease, nephrogenic diabetes insipidus, and polycytemia. 246
Atheroembolic renal disease 242
CHOLESTEROL CRYSTAL EMBOLISM: A RECOGNIZABLE CAUSE OF RENAL DISEASE 241
Malattia cistica della midollare (MCKD), Nefropatia iperuricemica familiare giovanile (FJHN) e Glomerulocisti (GCKD) sono causate da mutazioni dello stesso gene (UMOD) che determinano alterazioni del trasporto cellulare di uromodulina. 241
Uromodulin storage diseases: clinical aspects and mechanisms. 240
IgA nephropathy: the presence of familial disease does not confer an increased risk for progression 239
Exome sequencing identified MYO1E and NEIL1 as candidate genes for human autosomal recessive steroid-resistant nephrotic syndrome. 239
Renal outcome in patients with congenital anomalies of the kidney and urinary tract. 238
Autosomal Dominant tubulointerstitial Kidney Disease with Adult onset due to a novel Renin Mutation Mapping in the Mature protein 238
Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. 237
The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease. 236
Cis and trans regulatory elements in NPHS2 promoter: implications in proteinuria and progression of renal diseases 232
Genetic studies of IgA nephropathy: past, present, and future. 231
Urinary secretion and extracellular aggregation of mutant uromodulin isoforms 231
IgA nephropathy--the case for a genetic basis becomes stronger. 228
Familial vesicoureteral reflux: testing replication of linkage in seven new multigenerational kindreds 225
Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. 224
Coexistence of Different Circulating Anti-PodocyteAntibodies in Membranous Nephropathy 223
Copy number disorders are a Common Cause of Congenital Kidney Malformations 222
Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families 221
Localization of a gene for nonsyndromic renal hypodysplasia to chromosome 1p32-33. 220
Genetic approaches to human renal agenesis/hypoplasia and dysplasia. 219
Phenotypic expansion of DGKE-associated diseases. 218
Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial. 218
Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection. 218
Search for genetic association between IgA nephropathy and candidate genes selected by function or by gene mapping at loci IGAN2 and IGAN3 217
Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis 216
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens 211
The Case ∣ Familial occurrence of retinitis pigmentosa, deafness, and nephropathy. 208
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 200
Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: Protocol of a pilot randomised controlled trial 196
The progression from obesity to type 2 diabetes in Alström syndrome. 195
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 195
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 195
A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation. 192
Anemia emolitica autoimmune acquisita (AEAA) da incompatibilità minore ABO: un raro esempio di graft versus host disease (GVHD) in corso di trapianto di rene (TX). 191
Glomerular clusterin is associated with PKC-alpha/beta regulation and good outcome of membranous glomerulonephritis in humans 187
A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. 185
Uromodulin: from monogenic to multifactorial diseases. 184
Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. 183
A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model 183
A long term, randomized clinical trial to evaluate the effects of ramipril on the evolution of renal function in chronic nephropathies. 180
LES FORMES FAMILIALES DE NÉPHROPATHIE À IgA ÉTUDES CLINIQUE ET GÉNÉTIQUE 174
IDENTIFICATION OF A NEW LOCUS FOR MEDULLARY CYSTIC DISEASE ON CHROMOSOME 16 173
ORO-FACIO-DIGITAL SYNDROME 172
A large TSC2 and PKD1 gene deletion is associated with renal and extrarenal signs of autosomal dominant polycystic kidney disease 171
Berger's Disease 171
AUTOSOMAL DOMINANT MEDULLARY CYSTIC KIDNEY DISEASE 170
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection 169
Myroides odoratimimus urinary tract infection in an immunocompromised patient: An emerging multidrug-resistant micro-organism 159
Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure. 158
Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis. 158
The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors 155
Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis 153
Familial IgM mesangial nephropathy: a morphologic and immunogenetic study of three pedigrees. 151
Non-collagen genes role in digenic Alport syndrome 151
La sindrome oro-facio-digitale tipo 1: una causa infrequente di malattia cistica renale a carattere ereditario. 149
32 cases of familial primary glomerulonephritis: HLA do not play a role in the genetic mechanism of the disease. 144
[The role of magnetic resonance angiography in the assessment of arterial stenosis in the transplanted kidney] 144
Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial. 143
Clustering familiare di differenti forme di glomerulonefrite primitiva: studio Valtrompia: 143
An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes 143
Early histopathologic changes predicting long-term kidney transplant survival. 142
Immunogenetics of Henoch-Schoenlein disease. 142
Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. 141
Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. 141
The IgA nephropathy Biobank. An important starting point for the genetic dissection of a complex trait 141
Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. 140
Familial occurrence of primary glomerulonephritis: evidence for a role of genetic factors. 140
Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection? 138
[Hyperuricemia and Gout] 138
Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy 138
Atheroembolic renal disease. 137
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 137
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 137
Viral hepatitis in HBsAg-positive renal transplant patients treated with cyclosporin and steroids. 136
Totale 22.312
Categoria #
all - tutte 254.593
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 254.593


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021331 0 0 0 0 0 0 0 0 0 0 0 331
2021/20223.095 134 746 27 101 55 94 171 202 172 339 284 770
2022/20231.966 518 20 32 102 118 644 6 146 193 17 89 81
2023/20242.787 104 49 153 244 77 274 122 80 1.022 45 63 554
2024/20257.332 48 46 53 839 965 576 996 200 721 386 1.588 914
2025/202616.320 1.275 2.311 1.457 2.628 1.215 980 2.517 709 1.069 1.233 724 202
Totale 57.930